AcelRx Pharmaceuticals has hired James Welch as chief financial officer (CFO). Previously, he was CFO at Cerimon Pharmaceuticals, a privately held company focusing on developing pain products. Before Cerimon, Welch was CFO and corporate secretary at Rigel Pharmaceuticals.
Earlier in his career, Welch was CFO of Biocircuits Corporation, a public medical diagnostic company, and held various financial management positions at technology firms in Silicon Valley, such as NeXT Computer and Avantek.
UK firms investment in training and development will increase, on average, by a fifth in the next year, claims Robert Half recruitment after interviewing 100 financial services (FS) executives.
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.